In the group of patients with dyslipidemia and the confirmed presence of unstable atherosclerotic plaque, plasma levels of OPG, OPN, MMP-2, and MMP-9 are significantly higher compared to the group of healthy people. Here, MMP2 is linked to metabolic syndrome.